Immunome, Inc. (IMNM)

NASDAQ: IMNM · Real-Time Price · USD

11.38

+0.31 (2.80%)

Jul 23, 2025, 3:38 PM - Market open

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2023
Period Ending	Dec '23 Dec 31, 2023
Biotechnology	14.02M

Revenue by Geography

Fiscal year is January - December.

Fiscal Year	FY 2023
Period Ending	Dec '23 Dec 31, 2023
United States	14.02M